Skip to content

Price / sales at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
0.2×-0.1×
Ardelyx logo
ArdelyxARDX
3.4×+0.2×
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
7.7×+0.5×
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
1.7×+0.1×
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
1.9×-0.3×
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
5.1×-0.4×

Other financials

Income statement

See full
Revenue$106.5M+159%
Operating income$72.6M+349%
Net income$40.8M+209%
EPS (diluted)$0.24+204%

Balance sheet

See full
Cash & equivalents$220.5M+103%
Total debt$212.4M+1,323%
Total equity-$217.1M+35.0%
Total assets$434.6M+32.8%

Cash flow

See full
Operating cash flow$5.1M-74.3%
CapEx-
Free cash flow$74.6M+390%

Valuation

See full
Market cap$632.12M+457%
Enterprise value$624M+3,024%
P/E6.2×

Profitability

See full
Gross margin99.2%
Operating margin55.4%+38.7pp
Net margin28.3%+22.3pp
FCF margin24.7%-11.1pp

Returns & leverage

See full
Return on equity29.7%-138pp
Debt / equity-0.5×
Current ratio1.4×-1.9×

Where this comes from

Calculated from Ironwood Pharmaceuticals’s reported figures.

Based on the most recent quarter.

The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ironwood Pharmaceuticals's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ironwood Pharmaceuticals's price / sales?
Ironwood Pharmaceuticals (IRWD) reported price / sales of 1.6× in Q1 2026.
How has Ironwood Pharmaceuticals's price / sales changed year-over-year?
Ironwood Pharmaceuticals's price / sales increased by 113.8% year-over-year, from 0.7× to 1.6×.
What is the long-term trend for Ironwood Pharmaceuticals's price / sales?
Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's price / sales has grown at a -17.0% compound annual growth rate (CAGR), from 4.7× to 1.9×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.